Claris Biotherapeutics
Jersey City, NJ
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.
clarisbio.comCompany Details
Founded
- 2018
Employees
- Between 2 - 10 employees
Raised
- $104,799,992
Headquarters Location
- Jersey City, NJ
Public
- No
Acquired
- No
CEO
Clarke Atwell
Founders
- Reza DanaSunil Chauhan
Company Collections
These are collections Claris Biotherapeutics is a part of. Click on the collection name to view similar companies.
Claris Biotherapeutics' Industries
Claris Biotherapeutics Headquarters Location
299 Pavonia Avenue 3-8, Jersey City, NJ 07302
Total Amount Raised: $104,799,992
Claris Biotherapeutics Funding Rounds
Debt Financing
$3,299,999
Series A
$57,000,000
Series A Investors
Henderson Global InvestorsNovo HoldingsMass General BrighamRA Capital ManagementSeries Unknown
$44,499,994
Funding info provided by Diffbot.
Claris Biotherapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Claris Biotherapeutics.